Skip to content

Find our latest news, stories and press releases

Delivering long-term value for our stakeholders

Explore career opportunities and more

Impacting health for humanity

  1. Home/
  2. News/
  3. Innovation/
  4. About the Johnson & Johnson Women in STEM²D Scholars Award Program

About the Johnson & Johnson Women in STEM²D Scholars Award Program

WiSTEM microscope

The Johnson & Johnson Scholars Award Program aims to fuel the development of female STEM2D leaders and feed the STEM2D talent pipeline by awarding and sponsoring women at critical points in their research careers, in each of the STEM2D disciplines: Science, Technology, Engineering, Math, Manufacturing and Design.

The awards will fund one woman per discipline who has completed her advanced degree, who is working as an assistant professor or global equivalent and who is not yet tenured at an accredited university or design institution. The goal is to fuel the research passion of the awarded women and inspire career paths in their respective STEM2D fields.

By offering these awards, Johnson & Johnson hopes to play an influential role in STEM2D breakthroughs in the future.

WiSTEM2D Scholars Award

The Johnson & Johnson WiSTEM²D Scholars Award Program will help develop female leaders and support innovation in STEM fields.

More from Johnson & Johnson

6 ways Johnson & Johnson is using AI to help advance healthcare

Artificial intelligence is revolutionizing healthcare—from improving surgical training and procedures to equipping healthcare providers with insights and personalizing care for patients around the world. See how the company is harnessing its extraordinary power.

How Johnson & Johnson is advancing the fight against Alzheimer’s disease

After decades of commitment to understanding this neurodegenerative disease, company scientists have developed innovative therapies and tools that can potentially slow its progression and ease the psychological toll on patients and caretakers. A cure is still elusive—but preventing the disease may be within reach.

Is this the end of one-size-fits-all treatments for depression?

Learn how Johnson & Johnson is working to better address the needs of the 7 in 10 people with depression whose treatments aren’t providing enough relief.